The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Role for protease activity in visceral pain in irritable bowel syndrome
Open accessAbstract
Mediators involved in the generation of symptoms in patients with irritable bowel syndrome (IBS) are poorly understood. Here we show that colonic biopsy samples from IBS patients release increased levels of proteolytic activity (arginine cleavage) compared to asymptomatic controls. This was dependent on the activation of NF-kappaB. In addition, increased proteolytic activity was measured in vivo, in colonic washes from IBS compared with control patients. Trypsin and tryptase expression and release were increased in colonic biopsies from IBS patients compared with control subjects. Biopsies from IBS patients (but not controls) released mediators that sensitized murine sensory neurons in culture. Sensitization was prevented by a serine protease inhibitor and was absent in neurons lacking functional protease-activated receptor-2 (PAR2). Supernatants from colonic biopsies of IBS patients, but not controls, also caused somatic and visceral hyperalgesia and allodynia in mice, when administered into the colon. These pronociceptive effects were inhibited by serine protease inhibitors and a PAR2 antagonist and were absent in PAR2-deficient mice. Our study establishes that proteases are released in IBS and that they can directly stimulate sensory neurons and generate hypersensitivity symptoms through the activation of PAR2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, some studies failed to demonstrate increased activated mast cells in IBS patients (35, 36, 57, 58, 168) and there are no consistent differences in the tissue concentrations of activated mast cells in patients with different IBS subtypes (36, 189).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [35]
In the citing paper
“Other studies have reported elevated levels of histamine and tryptase release in patients with IBS compared with controls (11, 13, 35, 73).”
From Intestinal microbiota and immune function in the pathogenesis of irritable bowel syndrome (2013) · cites this paper as [35]
In the citing paper
“For example, Trypsin-like activity and tryptase release are increased in colonic biopsies from IBS patients.7,58”
From The emerging roles of bacterial proteases in intestinal diseases (2023) · cites this paper as [58]
In the citing paper
“Similar to IBD, studies in mice and humans have provided evidence that host- and bacterial-derived proteases may contribute to pathogenesis and symptom generation.7,13,57,58”
From The emerging roles of bacterial proteases in intestinal diseases (2023) · cites this paper as [58]
In the citing paper
“Biopsy supernatants from IBS patients have also been shown to excite spinal afferent neurons via PAR-2 activation.7,58,155”
From The emerging roles of bacterial proteases in intestinal diseases (2023) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Uehara, A., Muramoto, K., Takada, H., & Sugawara, S. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.11.5690 · Cited by 157
RetractedBarbara, G., Stanghellini, V., De Giorgio, R., Cremon, C., Cottrell, G. S., Santini, D., Pasquinelli, G., Morselli-Labate, A. M., Grady, E. F., Bunnett, N. W., et al. (2004) · Gastroenterology · doi:10.1053/j.gastro.2003.11.055 · Cited by 1,475
Self-citationSpiller, R. C., Jenkins, D., Thornley, J. P., Hebden, J. M., Wright, T., Skinner, M., & Neal, K. R. (2000) · Gut · doi:10.1136/gut.47.6.804 · Cited by 1,155
Postinfectious Irritable Bowel Syndrome
Spiller, R., & Garsed, K. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.074 · Cited by 1,024
Two types of human mast cells that have distinct neutral protease compositions.
Irani, A.-M. A., Schechter, N. M., Craig, S. S., DeBlois, G., & Schwartz, L. B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4464 · Cited by 1,007
Altered rectal perception is a biological marker of patients with irritable bowel syndrome
Mertz, H., Naliboff, B. D., Munakata, J., Niazi, N., & Mayer, E. A. (1995) · Gastroenterology · doi:10.1016/0016-5085(95)90267-8 · Cited by 976
Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism
Steinhoff, M. S., Vergnolle, N., Young, S. H., Tognetto, M., Amadesi, S., Ennes, H. S., Trevisani, M., Hollenberg, M. D., Wallace, J. L., Caughey, G. H., et al. (2000) · Nature Medicine · doi:10.1038/72247 · Cited by 936
Self-citationPossible new role for NF-κB in the resolution of inflammation
Lawrence, T., Gilroy, D. W., Colville‐Nash, P., & Willoughby, D. A. (2001) · Nature Medicine · doi:10.1038/nm1201-1291 · Cited by 753
Malinen, E., Rinttila, T., Kajander, K., Matto, J., Kassinen, A., Krogius, L., Saarela, M., Korpela, R., & Palva, A. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40312.x · Cited by 699
Proteinase-activated receptor-2 and hyperalgesia: A novel pain pathway
Vergnolle, N., Bunnett, N. W., Sharkey, K. A., Brussee, V., Compton, S. J., Grady, E. F., Cirino, G., Gerard, N. P., Basbaum, A. I., Andrade‐Gordon, P., et al. (2001) · Nature Medicine · doi:10.1038/89945 · Cited by 465
Self-citationAmadesi, S., Nie, J., Vergnolle, N., Cottrell, G. S., Grady, E. F., Trevisani, M., Manni, C., Geppetti, P., McRoberts, J. A., Ennes, H. S., et al. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5679-03.2004 · Cited by 412
Self-citationInduction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2.
Cénac, N., Coelho, A., Nguyen, C., Compton, S., Andrade-Gordon, P., MacNaughton, W., Wallace, J., Hollenberg, M., Bunnett, N., Garcia-Villar, R., et al. (2002) · American Journal of Pathology · doi:10.1016/s0002-9440(10)64466-5 · Cited by 386
Self-citationSpiller, R. E. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00324-x · Cited by 353
Terminal ileal mucosal mast cells in irritable bowel syndrome
Weston, A. P., Biddle, W. L., Bhatia, P. S., & Miner, P. B. (1993) · Digestive Diseases and Sciences · doi:10.1007/bf01303164 · Cited by 338
Thompson, W., Irvine, E. J., Paré, P., Ferrazzi, S., & Rance, L. (2002) · Digestive Diseases and Sciences · doi:10.1023/a:1013208713670 · Cited by 330
Dai, Y., Moriyama, T., Higashi, T., Togashi, K., Kobayashi, K., Yamanaka, H., Tominaga, M., & Noguchi, K. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.0454-04.2004 · Cited by 301
Philip, S., Bulbule, A., & Kundu, G. C. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103334200 · Cited by 247
Miller, H. R. P., & Pemberton, A. D. (2002) · Immunology · doi:10.1046/j.1365-2567.2002.01375.x · Cited by 230
Coelho, A.-M., Vergnolle, N., Guiard, B. P., Fioramonti, J., & Bueno, L. P. (2002) · Gastroenterology · doi:10.1053/gast.2002.32387 · Cited by 212
Self-citationIs Irritable Bowel Syndrome a Low-Grade Inflammatory Bowel Disease?
Berčík, P., Verdu, E. F., & Collins, S. M. (2005) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2005.02.007 · Cited by 207
Therapeutic Promise of Proteinase-Activated Receptor-2 Antagonism in Joint Inflammation
Kelso, E. B., Lockhart, J. C., Hembrough, T., Dunning, L., Plevin, R. J., Hollenberg, M. D., Sommerhoff, C. P., McLean, J. S., & Ferrell, W. R. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.093807 · Cited by 195
Reed, D. E., Barajas‐Lopez, C., Cottrell, G., Velazquez‐Rocha, S., Dery, O., Grady, E. F., Bunnett, N. W., & Vanner, S. J. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2002.032011 · Cited by 192
Self-citationCorvera, C. U., Déry, O., McConalogue, K., Gamp, P. D., Thoma, M. S., Al‐Ani, B., Caughey, G. H., Hollenberg, M. D., & Bunnett, N. W. (1999) · The Journal of Physiology · doi:10.1111/j.1469-7793.1999.0741s.x · Cited by 182
Self-citationHansen, K. K., Sherman, P. M., Cellars, L., Andrade‐Gordon, P., Pan, Z., Baruch, A., Wallace, J. L., Hollenberg, M. D., & Vergnolle, N. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409535102 · Cited by 176
Self-citationTrypsin IV, a Novel Agonist of Protease-activated Receptors 2 and 4
Cottrell, G. S., Amadesi, S., Grady, E. F., & Bunnett, N. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312090200 · Cited by 172
Self-citationAit-Belgnaoui, A., Bradesi, S., Fioramonti, J., Theodorou, V., & Bueno, L. (2005) · Pain · doi:10.1016/j.pain.2004.10.002 · Cited by 171
Symptomatic overlap between irritable bowel syndrome and microscopic colitis
Limsui, D., Pardi, D. S., Camilleri, M., Loftus, E. V., Kammer, P. P., Tremaine, W. J., & Sandborn, W. J. (2006) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20059 · Cited by 167
CLINICAL RELEVANCE OF PROTEINASE ACTIVATED RECEPTORS (PARS) IN THE GUT
Vergnolle, N. (2005) · Gut · doi:10.1136/gut.2004.048876 · Cited by 166
Self-citationMaukonen, J., Satokari, R., Mättö, J., Söderlund, H., Mattila-Sandholm, T., & Saarela, M. (2006) · Journal of Medical Microbiology · doi:10.1099/jmm.0.46134-0 · Cited by 156
Vergnolle, N., MacNaughton, W. K., Al‐Ani, B., Saifeddine, M., Wallace, J. L., & Hollenberg, M. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7766 · Cited by 154
Self-citationThe putative role of inflammation in the irritable bowel syndrome
Collins, S. M., PICHE, T., & Rampal, P. (2001) · Gut · doi:10.1136/gut.49.6.743 · Cited by 154
Cenac, N., Chin, A. C., Garcia‐Villar, R., Salvador‐Cartier, C., Ferrier, L., Vergnolle, N., Buret, A. G., Fioramonti, J., & Bueno, L. (2004) · The Journal of Physiology · doi:10.1113/jphysiol.2004.061721 · Cited by 140
Self-citationThompson, W. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.03.011 · Cited by 124
Visceral perception: inflammatory and non-inflammatory mediators
Bueno, L. P., & Fioramonti, J. (2002) · Gut · doi:10.1136/gut.51.suppl_1.i19 · Cited by 118
Gao, C., Liu, S., Hu, H., Gao, N., Kim, G. Y., Xia, Y. L., & Wood, J. D. (2002) · Gastroenterology · doi:10.1053/gast.2002.36581 · Cited by 106
Enterokinase (enteropeptidase): comparative aspects
Light, A., & Jańska, H. (1989) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(89)90133-3 · Cited by 105
Proteinase‐activated receptor‐1 agonists attenuate nociception in response to noxious stimuli
Asfaha, S., Brussee, V., Chapman, K., Zochodne, D. W., & Vergnolle, N. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704568 · Cited by 104
Self-citationExpression of Protease-Activated Receptor 2 in Ulcerative Colitis
Kim, J.-A., Choi, S.-C., Yun, K.-J., Kim, D.-K., Han, M.-K., Seo, G.-S., Yeom, J.-J., Kim, T.-H., Nah, Y.-H., & Lee, Y.-M. (2003) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200307000-00002 · Cited by 96
Inflammation as a basis for functional GI disorders
Spiller, R. E. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.04.002 · Cited by 93
Colitis induced by proteinase-activated receptor-2 agonists is mediated by a neurogenic mechanism
Nguyen, C., Coelho, A.-M., Grady, E., Compton, S. J., Wallace, J. L., Hollenberg, M. D., Cénac, N., Villar, R. G., Bueno, L. P., Steinhoff, M. S., et al. (2003) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y03-080 · Cited by 92
Self-citationNeonatal immune challenge alters nociception in the adult rat
Lomax, L. B., Spencer, S. J., Mouihate, A., Vergnolle, N., & Pittman, Q. J. (2005) · Pain · doi:10.1016/j.pain.2005.09.022 · Cited by 83
Self-citationHiramitsu, T., Yasuda, T., Ito, H., Shimizu, M., Julovi, S. M., Kakinuma, T., Akiyoshi, M., Yoshida, M., & Nakamura, T. (2006) · Rheumatology · doi:10.1093/rheumatology/kel026 · Cited by 75
Kawabata, A., Kuroda, R., Nagata, N., Kawao, N., Masuko, T., Nishikawa, H., & Kawai, K. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704211 · Cited by 74
Philip, S., Bulbule, A., & Kundu, G. C. (2004) · Glycoconjugate Journal · doi:10.1007/s10719-004-5533-7 · Cited by 71
Green, B. T., Bunnett, N. W., Kulkarni, A. P., Steinhoff, M. S., & Brown, D. R. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38916-5 · Cited by 70
Self-citationWhat activates visceral afferents?
Grundy, D. (2004) · Gut · doi:10.1136/gut.2003.033415 · Cited by 67
Activation of ion secretion via proteinase-activated receptor-2 in human colon
Mall, M. A., Gonska, T. Y., Thomas, J., Hirtz, S., Schreiber, R., & Kunzelmann, K. (2002) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00137.2001 · Cited by 67
Irritable bowel syndrome and inflammatory bowel disease: interrelated diseases?
Quigley, E. M. M. (2005) · Chinese Journal of Digestive Diseases · doi:10.1111/j.1443-9573.2005.00202.x · Cited by 65
Barau, E., & Dupont, C. M. (1990) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-199007000-00015 · Cited by 64
Macfarlane, S. R., Sloss, C. M., Cameron, P., Kanke, T., McKenzie, R. C., & Plevin, R. J. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706204 · Cited by 62
Cuffe, J. E., Bertog, M., Velázquez‐Rocha, S., Déry, O., Bunnett, N. W., & Korbmacher, C. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2001.013159 · Cited by 61
Self-citationLarsson, M., ARVIDSSON, S., Ekman, C., & Bayati, A. I. (2003) · Neurogastroenterology & Motility · doi:10.1046/j.1365-2982.2003.00418.x · Cited by 59
Mechanisms in IBS: something old, something new, something borrowed…
Camilleri, M. (2005) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00632.x · Cited by 54
c-Src Mediates Thrombin-Induced NF-κB Activation and IL-8/CXCL8 Expression in Lung Epithelial Cells
Lin, C., Cheng, H.-W., Hsu, M., Chen, M.-C., Lin, C., & Chen, B.-C. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.5.3427 · Cited by 53
Mishra, D. P., Pal, R., & Shaha, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508648200 · Cited by 53
Dual effect mediated by protease‐activated receptors on the mechanical activity of rat colon
Mulè, F., Baffi, M. C., & Cerra, M. C. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704746 · Cited by 51
Stimulation of proteinase-activated receptor 2 excites jejunal afferent nerves in anaesthetised rats
Kirkup, A. J., Jiang, W., Bunnett, N. W., & Grundy, D. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.049387 · Cited by 50
Uehara, A., Muramoto, K., Imamura, T., Nakayama, K., Potempa, J., Travis, J. W., Sugawara, S., & Takada, H. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.9.6076 · Cited by 48
Agonists of proteinase-activated receptor 2 excite guinea pig ileal myenteric neurons
Linden, D. R., Manning, B. P., Bunnett, N. W., & Mawe, G. M. (2001) · European Journal of Pharmacology · doi:10.1016/s0014-2999(01)01447-9 · Cited by 47
Self-citationPAR-2 agonists induce contraction of murine small intestine through neurokinin receptors
Zhao, A., & Shea‐Donohue, T. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00064.2003 · Cited by 33
Johanson, J. F. (2004) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2004.00550.x · Cited by 31
The pathophysiology of irritable bowel syndrome.
Schwetz, I., Bradesi, S., & Mayer, E. A. (2004) · PubMed · Cited by 24
Treatments targeting putative mechanisms in irritable bowel syndrome
Cremonini, F., & Talley, N. J. (2005) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep0096 · Cited by 23
Thompson, W. G. (1999) · Gut · doi:10.1136/gut.45.2008.ii80 · Cited by 16
Mouse mast cells express the tryptic protease neuropsin/Prss19
Wong, G. W., Yang, Y., Yasuda, S., Li, L., & Stevens, R. L. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00339-5 · Cited by 5
Simmering Innards: Does Irritable Bowl Syndrome Have an Immunological Basis?
Andrews, C. N., & Shaffer, E. A. (2004) · Canadian Journal of Gastroenterology · doi:10.1155/2004/707528 · Cited by 2
Self-citation
Flagged first, then by citations
Research works printed but not linked: 5
- Schwetz, 2004, Minerva Med., 95, 419
- Green, 2000, J. Pharmacol. Exp. Ther., 295, 410
- Barbara, 2002, Gastroenterology., 122, A276.
- Thompson, 1999, Gut., 45(Suppl. 2), II80
- Limsui, 2005, Gastroenterology., 128, A330.
Cited by
Sorted by citations
Enck, P., Aziz, Q., Barbara, G., Farmer, A. D., Fukudo, S., Mayer, E. A., Niesler, B., Quigley, E. M. M., Rajilić-Stojanović, M. D., Schemann, M., et al. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.14 · Cited by 1,102
Self-citationBrain-gut-microbe communication in health and disease
Grenham, S., Clarke, G., Cryan, J. F., & Dinan, T. G. (2011) · Frontiers in Physiology · doi:10.3389/fphys.2011.00094 · Cited by 952
“Cenac et al. (2007) demonstrated increased proteolytic activity in colonic washes from IBS compared with control patients while the analysis of TLR expression in colonic biopsies has demonstrated increased expression of TLR4 and TLR5 and decreased levels of TLR7 and TLR8 in IBS patients (Brint et…”
Intestinal microbiota in functional bowel disorders: a Rome foundation report
Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939
Self-citationPathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions
Öhman, L., & Simrén, M. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.4 · Cited by 617
“Increased numbers of mucosal mast cells have not, however, been shown consistently in all studies”
BackgroundPiche, T., Barbara, G., Aubert, P., Bruley des Varannes, S., Dainese, R., Nano, J. L., Cremon, C., Stanghellini, V, De Giorgio, R., Galmiche, J. P., et al. (2009) · Gut · doi:10.1136/gut.2007.140806 · Cited by 540
“Previous studies (10, 11) have shown that candidates such as protease and histamine are involved in the effects of SUP of IBS upon the neuronal excitability.”
Self-citation
Metadata
- Authors
- Cenac, N., Andrews, C. N., Holzhausen, M., Chapman, K., Cottrell, G., Andrade-Gordon, P., Steinhoff, M., Barbara, G., Beck, P., Bunnett, N. W., Sharkey, K. A., Ferraz, J. G. P., Shaffer, E., & Vergnolle, N.
- Affiliations
- University of Calgary (CA)
- University of California, San Francisco (US)
- University of Münster (DE)
- University of Bologna (IT)
- Corresponding author
- Vergnolle, Nathalie
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2007-03-01
- Volume
- 117
- Issue
- 3
- Pages
- 636-647
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1794118
- OpenAlex
- W2140528350
- Cited by
- 591
- References
- 66
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 22 · 2023: 19 · 2022: 21 · 2021: 24 · 2020: 26 · 2019: 27 · 2018: 25 · 2017: 32 · 2016: 37 · 2015: 28 · 2014: 36 · 2013: 38 · 2012: 41
- FWCI
- 39.19
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CentAUR (University of Reading) (submittedVersion)
- Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
- Funders
- Crohn's and Colitis Foundation
- Crohn's and Colitis Foundation of Canada
- Canadian Association of Gastroenterology
- Fondation pour la Recherche Médicale
- Alberta Heritage Foundation for Medical Research
- National Institutes of Health (DK43207, DK57480)
- Canadian Institutes of Health Research (DK43207)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 43207, R01DK043207, DK-57480, R56DK043207)
- Topics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Keywords
- irritable bowel syndrome, visceral pain, proteolytic activity, NF-κB, trypsin, tryptase, protease-activated receptor 2, sensory neuron sensitization, visceral hypersensitivity, allodynia, serine protease inhibitors, colonic biopsy
- MeSH terms
- Adult, alpha 1-Antitrypsin, Colon, Female, Humans, Hyperalgesia, Male, Middle Aged, Neurons, Afferent, Endopeptidases, Trypsin, Abdominal Pain, Serine Proteinase Inhibitors, NF-kappa B, Irritable Bowel Syndrome, Receptor, PAR-2, Tryptases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
